N -(coumarin-3-yl)cinnamamide Promotes Immunomodulatory, Neuroprotective, and Lung Function-Preserving Effects during Severe Malaria

ANKA (PbA) infection in mice resembles several aspects of severe malaria in humans, such as cerebral malaria and acute respiratory distress syndrome. Herein, the effects of -(coumarin-3-yl)cinnamamide (M220) against severe experimental malaria have been investigated. Treatment with M220 proved to pr...

Full description

Saved in:
Bibliographic Details
Published inPharmaceuticals (Basel, Switzerland) Vol. 17; no. 1; p. 46
Main Authors Gaio, Paulo, Cramer, Allysson, de Melo Oliveira, Natália Fernanda, Porto, Samuel, Kramer, Lucas, Nonato Rabelo, Rayane Aparecida, Pereira, Rafaela das Dores, de Oliveira Santos, Laura Lis, Nascimento Barbosa, César Luís, Silva Oliveira, Fabrício Marcus, Martins Teixeira, Mauro, Castro Russo, Remo, Matos, Maria João, Simão Machado, Fabiana
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 27.12.2023
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ANKA (PbA) infection in mice resembles several aspects of severe malaria in humans, such as cerebral malaria and acute respiratory distress syndrome. Herein, the effects of -(coumarin-3-yl)cinnamamide (M220) against severe experimental malaria have been investigated. Treatment with M220 proved to protect cognitive abilities and lung function in PbA-infected mice, observed by an object recognition test and spirometry, respectively. In addition, treated mice demonstrated decreased levels of brain and lung inflammation. The production and accumulation of microglia, and immune cells that produce the inflammatory cytokines TNF and IFN-γ, decreased, while the production of the anti-inflammatory cytokine IL-10 by innate and adaptive immune cells was enhanced. Treatment with M220 promotes immunomodulatory, neuroprotective, and lung function-preserving effects during experimental severe malaria. Therefore, it may be an interesting therapeutic candidate to treat severe malaria effects.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
ISSN:1424-8247
1424-8247
DOI:10.3390/ph17010046